| Autor: |
Sonawane A; Oncoseek Bio-Acasta Health, India., Vadloori B; Oncoseek Bio-Acasta Health, India., Poosala S; Oncoseek Bio-Acasta Health, India., Kandarova H; Centre of Experimental Medicine, Slovak Academy of Science, Slovakia., Kulkarni M; Lumiseek, India., Olayanju A; Manchester BIOGEL, UK., Dey T; Savitribai Phule Pune University, India., Saxena U; ReaGene Biosciences, India., Smirnova L; Johns Hopkins Bloomberg School of Public Health, USA., Kanda Y; National Institute of Health Sciences, Japan., Reddy J; UR Advanced Therapeutics, India., Dravida S; Transcell Biologics, India., Biswas S; Wipro, India., Vinken M; Vrije Universiteit Brussel, Belgium., Gettayacamin M; Association for Accreditation of Laboratory Animal Care (AAALAC international), USA., Ahluwalia A; University of Pisa, and Interuniversity Center for the Promotion of 3Rs Principles in Teaching and Research (Centro 3R), Italy., Mondini F; Techniplast, Italy., Bhattacharya S; The Jackson Laboratory, USA., Kulkarni P; Dr Reddy's Laboratories, India., Jacobsen KR; Ellegaard Göttingen Minipigs, Denmark., Vangala S; ReaGene Biosciences, India., Millás AL; 3D Biotechnology Solutions, Brazil. |
| Abstrakt: |
The fact that animal models fail to replicate human disease faithfully is now being widely accepted by researchers across the globe. As a result, they are exploring the use of alternatives to animal models. The time has come to refine our experimental practices, reduce the numbers and eventually replace the animals used in research with human-derived and human-relevant 3-D disease models. Oncoseek Bio-Acasta Health, which is an innovative biotechnology start-up company based in Hyderabad and Vishakhapatnam, India, organises an annual International Conference on 3Rs Research and Progress. In 2021, this conference was on 'Advances in Research Animal Models and Cutting-Edge Research in Alternatives'. This annual conference is a platform that brings together eminent scientists and researchers from various parts of the world, to share recent advances from their research in the field of alternatives to animals including new approach methodologies, and to promote practices to help refine animal experiments where alternatives are not available. This report presents the proceedings of the conference, which was held in hybrid mode (i.e. virtual and in-person) in November 2021. |
